Rational Design of Protein C Activators

Area of Science:

• Biochemistry
• Hematology
• Protein Engineering

Background:

• Thrombin is a protease with procoagulant and proinflammatory roles.
• Thrombin activates anticoagulant protein C (APC) via thrombomodulin and endothelial protein C receptor.
• APC possesses anticoagulant, anti-inflammatory, and regenerative properties.

Purpose of the Study:

• To develop a fusion protein that acts as a protein C activator.
• To create a potential therapeutic for thrombotic disorders and a diagnostic tool for protein C deficiency.
• To engineer a protein C activator independent of exogenous thrombomodulin.

Main Methods:

• Constructed a fusion protein linking thrombin and the EGF456 domain of thrombomodulin via a peptide linker.
• Assessed the fusion protein's ability to activate protein C and prolong clotting time.
• Evaluated the fusion protein's diagnostic capability for protein C deficiency in human plasma.

Main Results:

• The fusion protein successfully mimicked the thrombin-thrombomodulin complex's functions.
• It generated pharmacologically relevant quantities of APC, prolonging clotting time.
• The fusion protein effectively diagnosed protein C deficiency without requiring additional thrombomodulin.

Conclusions:

• The developed fusion protein is a functional protein C activator.
• It holds promise as a therapeutic agent for thrombotic conditions and a diagnostic tool.
• This engineered protein represents a significant advancement over existing anticoagulant thrombin derivatives.